Rachel Chamanga

Datos Biográficos

ID7726512
NOMBRERachel Chamanga
NOMBRESRachel
APELLIDOChamanga
FIRMACHAMANGA R
AFILIACIONESElizabeth Glaser Pediatric AIDS Foundation
ORCID0000-0003-1298-7669
VERIFICADOSí
TOTAL DE OBRAS11
TOTAL DE CITAS0
TOTAL COMO AUTOR11
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2019
AÑO MÁS RECIENTE DE PUBLICACIÓN2026
ÍNDICE H0

  • Retention in HIV care before and after implementation of a case management program in Malawi

    Open AccessLucky Makonokaya, Shalom Dunga et al.ARTICLEBMC Public Health2026

  • Enhancing Sars-CoV-2 surveillance in Malawi using telephone syndromic surveillance from July 2020 to April 2022

    Open AccessGodfrey Woelk, Thulani Maphosa et al.ARTICLEBMJ Global Health2024

    INTRODUCTION: Monitoring the SARS-CoV-2 pandemic in low-resource countries such as Malawi requires cost-effective surveillance strategies. This study explored the potential utility of phone-based syndromic surveillance in terms of its reach, monitoring trends in reported SARS-CoV-2-like/influenza-like symptoms (CLS/ILS), SARS-CoV-2 testing and mortality. METHODS: Mobile phone-based interviews were conducted between 1 July 2020 and 30 April 2022, …

  • Barriers and facilitators to implementing six monthly multi-month dispensing of antiretroviral therapy in two urban HIV clinics during the Covid-19 Era in Malawi

    Open AccessRachel Chamanga, Agatha Bula et al.ARTICLEPLOS Global Public Health2024

    Following the COVID-19 pandemic, the Malawi Government released a policy that promoted the scale-up of six-monthly multi-month dispensing (6-MMD) of antiretroviral therapy (ART) to people living with HIV in order to decrease congestion at health facilities and transmission of COVID-19. We evaluated the barriers and facilitators to implementing the scale-up of 6-MMD.We conducted a cross-sectional study and collected quantitative and qualitative da…

  • Factors associated with Covid-19 vaccine receipt among mobile phone users in Malawi

    Open AccessLucky Makonokaya, Lester Kapanda et al.ARTICLEPLOS Global Public Health2024

    Malawi recommended COVID-19 vaccines for adults aged ≥18 years in March 2021. We assessed factors associated with receiving COVID-19 vaccines in Malawi as part of a telephone-based syndromic surveillance survey. We conducted telephone-based syndromic surveillance surveys with questions on COVID-19 vaccine receipt among adults (≥18 years old) upon verbal consent from July 2021 to April 2022. We used random digit dialing to select mobile phone numb…

  • Improving HIV testing and retention among adolescents and youths

    Open AccessRachel Chamanga, Tessa Musukwa et al.ARTICLEPLOS Global Public Health2024

    Adolescents and youth living with HIV (AYLHIV) often face significant challenges in HIV care. Elizabeth Glaser Pediatric AIDS Foundation in Malawi implemented the Red-Carpet Program (RCP) to provide fast-tracked services for AYLHIV in care.This study aimed to assess the effect of RCP on Provider-Initiated HIV testing, linkage to care and antiretroviral therapy (ART), and retention in care among AYLHIV in Blantyre, Malawi. This quasi-experimental …

  • Examining teen club attendance and viral load suppression among adolescents under differentiated HIV care in Malawi

    Open AccessRachel Chamanga, Tessa Musukwa et al.ARTICLEBMC Public Health2024

    Even amongst adolescents enrolled in teen clubs, teen club attendance is low and high HIV viremia prevails. A continual focus on adolescents is needed to promote consistent teen club attendance and consistent ART adherence among the adolescents enrolled in differentiated service delivery

  • Unlocking the potential

    Open AccessThulani Maphosa, Shalom Dunga et al.ARTICLEBMC Public Health2024

    This study provides insights into weight gain patterns in patients on DTG-based regimens compared with those on non-DTG regimens. Younger individuals (15-24 years) exhibited higher odds of weight gain, suggesting a need for increased surveillance in this age group. These findings contribute to the understanding DTG's potential effects on weight gain, aiding clinical decision making. Further research is required to comprehensively understand the u…

  • Early Effects of Scaling Up Dolutegravir-Based ARV Regimens Among Children Living with HIV in Malawi

    Open AccessLucky Makonokaya, Alice Maida et al.ARTICLEAIDS and Behavior2024

    Viral suppression (VS) in children has remained suboptimal compared to that in adults. We evaluated the impact of transitioning children weighing < 20 kg to a pediatric formulation of dolutegravir (pDTG) on VS in Malawi. We analyzed routine retrospective program data from electronic medical record systems pooled across 169 healthcare facilities in Malawi supported by the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF). We included children who…

  • Safety of Janssen Ad26.COV.S and Astra Zeneca AZD1222 Covid-19 Vaccines among Mobile Phone Users in Malawi

    Open AccessLucky Makonokaya, Lester Kapanda et al.ARTICLEInternational Journal of…2023

    The safety profiles of the Ad26.COV2.S and AZD1222 COVID-19 vaccines have not been described in the general population in Malawi. We present self-reported adverse events (AE) following the receipt of these vaccines in Malawi as part of a national syndromic surveillance survey. We conducted phone-based syndromic surveillance surveys among adults (≥18 years) with verbal consent. We used secure tablets through random digit dialing to select mobile p…

  • Understanding gender differences of people with HIV newly diagnosed or returning to care with advanced HIV disease in Malawi

    Open AccessLeila Katirayi, Thulani Maphosa et al.ARTICLEBMC Public Health2023

    NCT05510973, first registration 22/08/2022

  • Slow Acceptance of Universal Antiretroviral Therapy (ART) Among Mothers Enrolled in Impaact PROMISE Studies Across the Globe

    Open Accessfor the PROMISE study team, Lynda Stranix‐Chibanda et al.ARTICLEAIDS and Behavior2019

    The PROMISE trial enrolled asymptomatic HIV-infected pregnant and postpartum women not eligible for antiretroviral treatment (ART) per local guidelines and randomly assigned proven antiretroviral strategies to assess relative efficacy for perinatal prevention plus maternal/infant safety and maternal health. The START study subsequently demonstrated clear benefit in initiating ART regardless of CD4 count. Active PROMISE participants were informed …